These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 28127890
21. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase. Zeng DW, Dong J, Jiang JJ, Zhu YY, Liu YR. World J Gastroenterol; 2016 Nov 21; 22(43):9586-9594. PubMed ID: 27920479 [Abstract] [Full Text] [Related]
22. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis. Sanai FM, Babatin MA, Bzeizi KI, Alsohaibani F, Al-Hamoudi W, Alsaad KO, Al Mana H, Handoo FA, Al-Ashgar H, Alghamdi H, Ibrahim A, Aljumah A, Alalwan A, Altraif IH, Al-Hussaini H, Myers RP, Abdo AA. Clin Gastroenterol Hepatol; 2013 Nov 21; 11(11):1493-1499.e2. PubMed ID: 23811251 [Abstract] [Full Text] [Related]
23. MicroRNA panels as disease biomarkers distinguishing hepatitis B virus infection caused hepatitis and liver cirrhosis. Jin BX, Zhang YH, Jin WJ, Sun XY, Qiao GF, Wei YY, Sun LB, Zhang WH, Li N. Sci Rep; 2015 Oct 12; 5():15026. PubMed ID: 26456479 [Abstract] [Full Text] [Related]
24. High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis. Leti F, Malenica I, Doshi M, Courtright A, Van Keuren-Jensen K, Legendre C, Still CD, Gerhard GS, DiStefano JK. Transl Res; 2015 Sep 12; 166(3):304-14. PubMed ID: 26001595 [Abstract] [Full Text] [Related]
25. Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study. Afdhal NH, Bacon BR, Patel K, Lawitz EJ, Gordon SC, Nelson DR, Challies TL, Nasser I, Garg J, Wei LJ, McHutchison JG. Clin Gastroenterol Hepatol; 2015 Apr 12; 13(4):772-9.e1-3. PubMed ID: 25528010 [Abstract] [Full Text] [Related]
26. Serum microRNA-29 levels correlate with disease progression in patients with chronic hepatitis B virus infection. Huang C, Zheng JM, Cheng Q, Yu KK, Ling QX, Chen MQ, Li N. J Dig Dis; 2014 Nov 12; 15(11):614-21. PubMed ID: 25138057 [Abstract] [Full Text] [Related]
27. miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan. Halász T, Horváth G, Pár G, Werling K, Kiss A, Schaff Z, Lendvai G. World J Gastroenterol; 2015 Jul 07; 21(25):7814-23. PubMed ID: 26167081 [Abstract] [Full Text] [Related]
28. Circulating let-7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C. Matsuura K, De Giorgi V, Schechterly C, Wang RY, Farci P, Tanaka Y, Alter HJ. Hepatology; 2016 Sep 07; 64(3):732-45. PubMed ID: 27227815 [Abstract] [Full Text] [Related]
29. Serum microRNA-124 is a novel biomarker for liver necroinflammation in patients with chronic hepatitis B virus infection. Wang JY, Mao RC, Zhang YM, Zhang YJ, Liu HY, Qin YL, Lu MJ, Zhang JM. J Viral Hepat; 2015 Feb 07; 22(2):128-36. PubMed ID: 25131617 [Abstract] [Full Text] [Related]
30. Expression profile of plasma microRNAs in nonsyndromic cleft lip and their clinical significance as biomarkers. Zou J, Li J, Li J, Ji C, Li Q, Guo X. Biomed Pharmacother; 2016 Aug 07; 82():459-66. PubMed ID: 27470385 [Abstract] [Full Text] [Related]
31. Diagnostic Role of Circulating miRNAs in the Grading of Chronic Hepatitis B-Related Liver Fibrosis: A Systematic Review and Meta-Analysis. Jiang T, Leng W, Zhong S. Lab Med; 2023 Sep 05; 54(5):479-488. PubMed ID: 36637253 [Abstract] [Full Text] [Related]
32. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. Ghosh A, Ghosh A, Datta S, Dasgupta D, Das S, Ray S, Gupta S, Datta S, Chowdhury A, Chatterjee R, Mohapatra SK, Banerjee S. Int J Cancer; 2016 Jun 01; 138(11):2732-44. PubMed ID: 26756996 [Abstract] [Full Text] [Related]
34. [Noninvasive evaluation of liver fibrosis in chronic hepatitis B patients]. Chen Y, Wang BE, Jia JD, Qian LX, Wang TL, Chen MH, Chen GY, He W, Ding HG, Yin SS, Zhang Y, Dong Z. Zhonghua Gan Zang Bing Za Zhi; 2003 Jun 01; 11(6):354-7. PubMed ID: 12837216 [Abstract] [Full Text] [Related]
36. [An analysis of the pathohistology of liver tissues, clinical features and prognostic factors of chronic hepatitis B virus carriers]. Wu CH, Si CW, Tian GS, Yu YY, Xu XY, Wang TL. Zhonghua Gan Zang Bing Za Zhi; 2007 Aug 01; 15(8):577-81. PubMed ID: 17711625 [Abstract] [Full Text] [Related]
37. Serum high-sensitivity C-reactive protein are associated with HBV replication, liver damage and fibrosis in patients with chronic hepatitis B. Ma LN, Liu XY, Luo X, Hu YC, Liu SW, Tang YY, Pan JL, Ding XC. Hepatogastroenterology; 2015 Aug 01; 62(138):368-72. PubMed ID: 25916065 [Abstract] [Full Text] [Related]
39. Characterization and identification of differentially expressed microRNAs during the process of the peribiliary fibrosis induced by Clonorchis sinensis. Yan C, Shen LP, Ma R, Li B, Li XY, Hua H, Zhang B, Yu Q, Wang YG, Tang RX, Zheng KY. Infect Genet Evol; 2016 Sep 01; 43():321-8. PubMed ID: 27267304 [Abstract] [Full Text] [Related]
40. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma. Xiao G, Zhu F, Wang M, Zhang H, Ye D, Yang J, Jiang L, Liu C, Yan L, Qin R. Dig Liver Dis; 2016 Oct 01; 48(10):1220-6. PubMed ID: 27599803 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]